Curaleaf Holdings, Inc. (CURLF)
Curaleaf Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Stamford, CT, US. The stock last traded at $9.96, up 0.91% on the session, giving a market capitalisation of $2.63B. On trailing twelve-month figures it carries a trailing P/E of -72.59, a net margin of -2.8%. Its beta of 1.63 implies it has historically moved more than the broad market.
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
Curaleaf Holdings, Inc. is most often compared with the following Healthcare names: